Theranos: Science Fact or Science Fiction?
The secretive diagnostic startup has been making headlines – but not always for the right reasons…
Roisin McGuigan |
There’s been a lot of buzz around the enigmatic health startup Theranos. The company’s disruptive diagnostic technology is designed with the aim of completely changing the way patients access sampling and testing, with plans to create a system whereby one fingerprick can be cheaply used for dozens of tests. And, as we’ve reported previously (1), the company has been cleared by the FDA to market its herpes simplex test in the US, and received a waiver which means the test can be used outside of traditional lab settings. Despite the fact that the company is still to release any details of their testing equipment, or to publish any peer-reviewed data (2), Theranos has garnered a huge amount of attention.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.